Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ivana Kolarov Bjelobrk"'
Autor:
Jelena Radić, Bojana Kožik, Ivan Nikolić, Ivana Kolarov-Bjelobrk, Tijana Vasiljević, Bojana Vranjković, Sanja Despotović
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 14, p 11745 (2023)
LOXL2, a copper-dependent amine oxidase, has emerged as a promising therapeutic target in hepatocellular carcinoma (HCC). Increased LOXL2 expression in HCC has been linked with an aggressive phenotype and represents a poor prognostic factor. Here, we
Externí odkaz:
https://doaj.org/article/68f0abec1cf340d58ec2f8d0043c3980
Autor:
Ivan Nikolić, Jelena Radić, Andrej Petreš, Aleksandar Djurić, Mladjan Protić, Jelena Litavski, Maja Popović, Ivana Kolarov-Bjelobrk, Saša Dragin, Lazar Popović
Publikováno v:
Cancers, Vol 14, Iss 19, p 4673 (2022)
Percutaneous transhepatic biliary drainage (PTBD) is a decompression procedure for malignant proximal biliary obstruction. In this research, over a six-year period, 89 patients underwent PTBD procedure for jaundice caused by malignant disease to rest
Externí odkaz:
https://doaj.org/article/68f8cdf832cc4896aaae482ab0bac923
Autor:
Milana Bosanac, Jelena Amidzic, Maja Stefanovic, Jelena Radic, Ivana Kolarov-Bjelobrk, Stefan Janicic, Zdenka Gojkovic, Bojana Lazic, Dejan Djokanovic, Aleksandra Misan, Biljana Cvetkovic, Alena Stupar, Nikola Martic, Bojana Andrejic-Visnjic
Publikováno v:
International Journal of Morphology. 41:231-236
Autor:
Bojana Andrejic-Visnjic, Golub Samardzija, Milana Bosanac, Teodora Pantic, Ivana Kolarov-Bjelobrk, Jelena Radic, Jelena Ilic-Sabo, Jelena Amidzic, Nemanja Gvozdenovic
Publikováno v:
International Journal of Morphology. 40:1236-1241
Autor:
Biljana Cvetković, Ivana Kolarov-Bjelobrk, Jelena Radić, Milana Bosanac, Stefan Janičić, Alena Stupar, Maja Samardžić-Lukić, Dragomir Ćuk, Vanja Tovilović, Bojana Andrejić-Višnjić
Publikováno v:
Hospital Pharmacology - International Multidisciplinary Journal. 9:1183-1188
Introduction: Carotenoids are liposoluble plant pigments. The most common in the human diet are a-carotene, b-carotene, b-cryptoxanthin, lycopene, lutein, and zeaxanthin. Methods: This article provides an overview of the findings on carotenoids to da
Autor:
Jasna Pesic, Vladimir Vidovic, Ivana Kolarov Bjelobrk, Jasna Trifunovic, Nemanja Petrovic, Jelena Radic, Bojana Vranjkovic, Bojana Andrejic Visnjic
Publikováno v:
Journal of Chemotherapy. 34:264-271
The choice of the anti-HER2 agent depends on country-specific availability, the specific, previously administered anti-HER2 therapy and the relapse-free interval, although there is not much published data on the use of lapatinib after progression on
Autor:
Gorana, Matovina Brko, Maja, Popovic, Masa, Jovic, Jelena, Radic, Milka, Bodlovic Kladar, Ivan, Nikolic, Vladimir, Vidovic, Ivana, Kolarov Bjelobrk, Biljana, Kukic, Svetlana, Salma, Jelena, Litavski, Nemanja, Petrovic, Bojana, Vranjkovic, Tatjana, Roganovic, Maja, Ruzic, Tihomir, Dugandzija, Lazar, Popovic
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
Recommendations and guidelines consider cancer patients a high-priority population for COVID-19 immunization. Vaccination process in Serbia began in January 2021 with four available vaccines. We have conducted a cross-sectional study investigating ca
Autor:
Jelena Radic, Ivana Kolarov-Bjelobrk, Tijana Vasiljevic, Bojana Vranjkovic, Vladimir Vidovic, Nemanja Petrovic
Publikováno v:
Medical review. 74:388-390
Introduction. Hepatocellular carcinoma is a serious problem for patients with hemophilia. Hepatitis C virus infection is the most common comorbidity in adult patients with inherited bleeding disorders, including hemophilia. Case Report. This is a cas
Autor:
Gorana Matovina-Brko, Milotka Fabri, Lazar Popovic, Danijela Petkovic, Jasna Trifunovic, Ivana Kolarov-Bjelobrk, Maja Ruzic
Publikováno v:
Journal of Chemotherapy. 26:180-183
Oncologists worldwide are often dealing with hepatitis C virus positive breast cancer patients, questioning adequate chemotherapy protocol, reduction of doses, delays, or even interruptions of treatment. We present a case of a woman in stage IIIB bre